| Website | barofold.com |
| Category | BioTech |
| Employees |
| TOTAL | $14.5M |
| FUNDING TOTAL | $14.5M |
| Venture Round, 3/06 Boulder Ventures The Peierls Foundation | $2.5M |
| Series A, 5/07 HBM BioVentures Boulder Ventures The Peierls Foundation | $12M |
BaroFold is a privately held biopharmaceutical company focused on the development of commercially attractive protein therapeutics for immunology indications. The company’s goal is to discover, develop and commercialize protein biologics, some of which incorporate its proprietary PreEMT™ high pressure folding technology along with other state-of-the-art technologies. This pipeline contains therapeutics with an Immunology focus, including Multiple Sclerosis, Rheumatoid Arthritis, and Asthma.
